Loading the section…
The price of Exagen Inc. (XGN) on October 9, 2026 is 8.42 USD, +3.06% on the day. Over 52 weeks the stock traded between 2.59 USD and 12.23 USD; the price now sits 60% of the way up that range. Over the past year the price changed by -23.32%. Market capitalization is 202.82 million USD, rank 17 among 23 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 3 November 2026 · Earnings calendar
Change over the period shown (line colour): −23.73 %
Exagen Inc. trades on Nasdaq under the ticker XGN. The company belongs to the Health care sector. The trading history on this page starts on 19 September 2019.
Over the past 52 weeks XGN has traded between 2.59 $ and 12.23 $. As of 9 October 2026 the price stood 60.48 % of the way from the 52-week low to the high.
Over one year XGN shares fell 23.32 %; over six months they rose 177.89 %. Volatility over 90 days is 83.05 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 3.0, below the sector median of 4.0. Price to book is 14.1, above the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 8.17 | 8.55 | 7.98 | 8.42 | 251,200 |
| 8 October 2026 | 8.24 | 8.25 | 7.98 | 8.17 | 362,300 |
| 7 October 2026 | 7.98 | 8.36 | 7.89 | 8.30 | 234,900 |
| 6 October 2026 | 8.53 | 8.70 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:1261 LIBERTY WAY, VISTA, CA, 92081, US
Exagen Inc. reported revenue of 68M $ and a net loss of 20M $ over the last four quarters. Net margin is −29.49 %. Revenue changed by +20.55 % year over year. Earnings per share are −0.90 $. Market capitalisation is 203M $.
XGN has a return on equity of −139.73 %, below the sector median of −41.68 %. Return on assets is −38.81 %, below the sector median of −32.11 %. Operating margin is −20.65 %, above the sector median of −26.84 %.
| 245M |
| CAICaris Life Sciences, Inc. | 29.70 | +8.00 % | 141M |
| GRALGRAIL, Inc. | 140.58 | +6.01 % | 139M |
| CELCCelcuity Inc. | 67.94 | +0.10 % | 92M |
| CDNACareDx, Inc. | 63.67 | +2.36 % | 79M |
| 8.09 |
| 8.19 |
| 271,800 |
| 5 October 2026 | 8.41 | 8.54 | 8.02 | 8.46 | 291,800 |
| 2 October 2026 | 7.99 | 8.20 | 7.78 | 8.17 | 617,300 |
| 1 October 2026 | 8.13 | 8.25 | 7.81 | 7.89 | 401,700 |
| 30 September 2026 | 8.39 | 8.41 | 8.07 | 8.13 | 214,200 |
| 29 September 2026 | 8.55 | 8.56 | 8.24 | 8.30 | 217,800 |
| 28 September 2026 | 8.65 | 8.69 | 8.45 | 8.48 | 231,000 |
| 25 September 2026 | 8.83 | 8.89 | 8.61 | 8.72 | 282,000 |
| 24 September 2026 | 8.44 | 8.86 | 8.28 | 8.74 | 341,400 |
| 23 September 2026 | 8.77 | 8.77 | 8.25 | 8.55 | 383,800 |
| 22 September 2026 | 8.71 | 8.88 | 8.53 | 8.74 | 264,400 |
| 21 September 2026 | 8.59 | 8.70 | 8.36 | 8.62 | 361,300 |
| 18 September 2026 | 7.87 | 8.42 | 7.87 | 8.41 | 351,700 |
| 17 September 2026 | 7.89 | 8.00 | 7.65 | 7.87 | 195,100 |
| 16 September 2026 | 7.56 | 7.94 | 7.56 | 7.78 | 329,500 |
| 15 September 2026 | 7.32 | 7.70 | 7.32 | 7.49 | 221,700 |
| 14 September 2026 | 6.97 | 7.38 | 6.91 | 7.35 | 192,600 |